Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Salaun-Martin
PDB49 Resource Use in Patients With Type 2 Diabetes (T2D) Who Initiated Exenatide BID (EXBID) or Starter Insulin (INS) Therapy: 6-Month Data From Choice
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pdb24 - Baseline Characteristics of German Diabetes Mellitus Type-2 Patients Who Initiated Insulin Usage: A Claims Data Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Exenatide Add-On to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients With Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Cost-Effectiveness Analysis of Exenatide Twice Daily (BID) Versus Insulin Glargine Once Daily (QD) as Add-On Therapy in Chinese Patients With Type 2 Diabetes Mellitus Inadequately Controlled by Oral Therapies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Diabetes Management and Healthcare Resource Use When Intensifying From Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
A Retrospective Database Analysis of Insulin Use Patterns in Insulin-Naïve Patients With Type 2 Diabetes Initiating Basal Insulin or Mixtures
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Initial Sulfonylurea Use and Subsequent Insulin Therapy in Older Subjects With Type 2 Diabetes Mellitus
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Health Care Resource Use and Costs in Patients With Type 2 Diabetes Mellitus After Treatment Initiation With Saxagliptin or Sitagliptin
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Once-Weekly Exenatide as Adjunct Treatment of Type 1 Diabetes Mellitus in Patients Receiving Continuous Subcutaneous Insulin Infusion Therapy
Canadian Journal of Diabetes
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
Exenatide Extended-Release: A Once Weekly Treatment for Patients With Type 2 Diabetes
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
